Abstract. Lung cancer is the leading cause of cancer death worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 85% of all lung cancers. At the time of diagnosis, it is ...
Cancer Res (2023) 83 (8_Supplement): LB210.
Cancer Res (2022) 82 (22_Supplement): A019.
Abstract. Despite demonstrated efficiency in antibody generation, classical immunization strategies and subsequent hybridoma generation often face strong limitations when it comes to complex targets ...
1Center for Engineering in Medicine and Surgery, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts. 2Krantz Family Center for Cancer Research, Massachusetts General ...
You do not currently have access to this content.
To help defray the rising costs of initial manuscript screening and publication, the AACR journals levy fees as detailed herein. Authors are required to confirm at the time of submission that they ...
1Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland. 2Centre for Haematology, Department of Immunology and Inflammation, Imperial ...
*Corresponding Author: Nooshin Mirkheshti, U.S. Center for Drug Evaluation and Research, Office of New Drugs, Office of Oncologic Diseases, Food and Drug Administration, Silver Spring, MD 20993.
For authors of Research Articles that have been declined for publication at an AACR journal, the AACR offers the corresponding author the option to easily transfer manuscript files and supporting ...
Cancer Res (2019) 79 (13_Supplement): 3278.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results